Currency in USD
Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 1 | 1 | 4 | 4 |
Avg. Estimate | 0.91 | 0.94 | 3.96 | 4.49 |
Low estimate | 0.91 | 0.94 | 3.91 | 4.4 |
High estimate | 0.91 | 0.94 | 4.01 | 4.55 |
Year ago EPS | 0.9 | 0.97 | 3.86 | 3.96 |
Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 2 | 2 | 5 | 5 |
Avg. Estimate | 8.91B | 9.46B | 41.2B | 41.97B |
Low estimate | 8.64B | 9.36B | 39.17B | 41.6B |
High estimate | 9.18B | 9.56B | 48.48B | 42.29B |
Year ago sales | 8.45B | 8.99B | 37.7B | 41.2B |
Sales growth (year/est) | 5.50% | 5.20% | 9.30% | 1.90% |
Earnings history | 30/03/2023 | 29/06/2023 | 29/09/2023 | 30/12/2023 |
---|
Est. EPS | 0.82 | 0.87 | 1.14 | 0.76 |
Actual EPS | 0.9 | 0.97 | 1.28 | 0.72 |
Difference | 0.08 | 0.1 | 0.14 | -0.04 |
Surprise % | 9.80% | 11.50% | 12.30% | -5.30% |
EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
Current estimate | 0.91 | 0.94 | 3.96 | 4.49 |
7 days ago | 0 | 0 | 4.03 | 4.55 |
30 days ago | 0 | 0 | 4.04 | 4.56 |
60 days ago | 0 | 0 | 3.99 | 4.45 |
90 days ago | 0 | 0 | 4 | 4.35 |
EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
Up last 7 days | N/A | N/A | 1 | N/A |
Up last 30 days | N/A | N/A | 2 | 1 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | 1 | 1 |
Growth estimates | GSK | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | 1.10% | N/A | N/A | N/A |
Next qtr. | -3.10% | N/A | N/A | N/A |
Current year | 2.60% | N/A | N/A | N/A |
Next year | 13.40% | N/A | N/A | N/A |
Next 5 years (per annum) | 4.80% | N/A | N/A | N/A |
Past 5 years (per annum) | -2.43% | N/A | N/A | N/A |